These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 33545792)
1. A meta-analysis of the effects of endothelial nitric oxide synthase 4ba polymorphism on renal interstitial fibrosis in diabetic nephropathy. Sun X; Gan H; Xia Y Ann Palliat Med; 2021 Jan; 10(1):633-645. PubMed ID: 33545792 [TBL] [Abstract][Full Text] [Related]
2. Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis. Dellamea BS; Pinto LC; Leitão CB; Santos KG; Canani LH BMC Med Genet; 2014 Jan; 15():9. PubMed ID: 24433471 [TBL] [Abstract][Full Text] [Related]
3. Associations between endothelial nitric oxide synthase polymorphisms and risk of diabetic nephropathy: an updated meta-analysis. Zhang Y; Xiao HQ; Zeng XT; Zuo HX; Xu YC Ren Fail; 2015 Nov; 37(10):312-26. PubMed ID: 26489520 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis on the relationship of eNOS 4b/a polymorphism and diabetic nephropathy susceptibility. Zeng R; Duan L; Sun L; Kong Y; Wu X; Wang Y; Xin G; Yang K Ren Fail; 2014 Nov; 36(10):1520-35. PubMed ID: 25296103 [TBL] [Abstract][Full Text] [Related]
5. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility. Zhou TB; Xu HL; Yin SS Ren Fail; 2013; 35(1):173-8. PubMed ID: 23113598 [TBL] [Abstract][Full Text] [Related]
6. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY J Diabetes Complications; 2008; 22(5):331-8. PubMed ID: 18413207 [TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase gene polymorphisms and the risk of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A; Shalaby SM; Abdelazim S; Abdelazim M; Ramadan A; Ismail MI; Fouad M Genet Test Mol Biomarkers; 2012 Jun; 16(6):574-9. PubMed ID: 22313046 [TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase (eNOS) 4b/a polymorphism and the risk of diabetic nephropathy in type 2 diabetes mellitus: A meta-analysis. Ma ZJ; Chen R; Ren HZ; Guo X; Chen JG; Chen LM; Meta Gene; 2014 Dec; 2():50-62. PubMed ID: 25606389 [TBL] [Abstract][Full Text] [Related]
9. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Shin Shin Y; Baek SH; Chang KY; Park CW; Yang CW; Jin DC; Kim YS; Chang YS; Bang BK Diabetes Res Clin Pract; 2004 Sep; 65(3):257-65. PubMed ID: 15331206 [TBL] [Abstract][Full Text] [Related]
10. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. El-Din Bessa SS; Hamdy SM Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of eNOS gene are associated with diabetic nephropathy: a meta-analysis. He Y; Fan Z; Zhang J; Zhang Q; Zheng M; Li Y; Zhang D; Gu S; Yang H Mutagenesis; 2011 Mar; 26(2):339-49. PubMed ID: 21084433 [TBL] [Abstract][Full Text] [Related]
12. [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy]. Li C; Dong Y; Lü W Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):729-32. PubMed ID: 11930675 [TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Zintzaras E; Papathanasiou AA; Stefanidis I Genet Med; 2009 Oct; 11(10):695-706. PubMed ID: 19773668 [TBL] [Abstract][Full Text] [Related]
14. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population. Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959 [TBL] [Abstract][Full Text] [Related]
15. Association of the endothelial nitric oxide synthase gene G894T polymorphism with the risk of diabetic nephropathy in Qassim region, Saudi Arabia-A pilot study. Mackawy AM; Khan AA; Badawy Mel-S Meta Gene; 2014 Dec; 2():392-402. PubMed ID: 25606424 [TBL] [Abstract][Full Text] [Related]
16. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis. Li Y; Tang K; Zhang Z; Zhang M; Zeng Z; He Z; He L; Wan C Mol Biol Rep; 2011 Jun; 38(5):3243-52. PubMed ID: 20177792 [TBL] [Abstract][Full Text] [Related]
17. Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study. Raina P; Sikka R; Gupta H; Matharoo K; Bali SK; Singh V; Bhanwer A Biochem Genet; 2021 Aug; 59(4):966-996. PubMed ID: 33609191 [TBL] [Abstract][Full Text] [Related]
18. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice. Takahashi T; Harris RC J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905 [TBL] [Abstract][Full Text] [Related]
19. Association between nitric oxide synthase (NOS3) gene polymorphisms and diabetic nephropathy: An updated meta-analysis. Dobrijević Z; Stevanović J; Robajac D; Penezić A; Četić D; Baralić M; Nedić O Mol Cell Endocrinol; 2024 May; 586():112197. PubMed ID: 38462124 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of three polymorphisms in the endothelial nitric oxide synthase gene (NOS3) and their effect on the risk of diabetic nephropathy. Zeng Z; Li L; Zhang Z; Li Y; Wei Z; Huang K; He L; Shi Y Hum Genet; 2010 Apr; 127(4):373-81. PubMed ID: 20049477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]